William Blair & Company LLC and JMP Securities LLC are joint book-running managers.Mizuho Securities USA Inc. is co-manager.
Description
Pfenex Inc. is a clinical-stage biotechnology company. The Company engaged in the development of difficult to manufacture and proteins, initially focused on biosimilar therapeutics (biosimilars). The Company’s product candidate is PF582, a biosimilar candidate to Lucentis (ranibizumab).
Address
10790 Roselle St
SAN DIEGO, CA 92121-1508
United States
SAN DIEGO, CA 92121-1508
United States
Website
http://www.pfenex.comKey stats and ratios
| Q1 (Mar '14) | 2013 | |
| Net profit margin | -60.28% | -34.09% |
| Operating margin | -59.54% | -56.21% |
| EBITD margin | - | -47.56% |
| Return on average assets | -19.92% | -12.55% |
| Return on average equity | - | - |
| Employees | 25 |
